Fintel reports that on January 28, 2025, Melius Research downgraded their outlook for Johnson Controls International ...

Johnson & Johnson (NYSE:JNJ), a global healthcare giant, finds itself at a critical juncture as it navigates a complex landscape of opportunities and challenges. The company's recent performance and ...

Jim Cramer in a latest program on CNBC discussed the reasons behind the recent market declines after the ISM Services Index ...

Barclays raised the firm’s price target on Johnson & Johnson to $166 from $159 and keeps an Equal Weight rating on the shares. The company ...

Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to help ...

The microbial ecosystems within our mouths may affect our cognitive function as we age, according to a study. Interventions such as prebiotics, including dietary nitrate, have potential for delaying ...

HistoSonics, a medical device company backed by Johnson & Johnson’s venture capital arm, is exploring the possibility of a U.S. initial ...

HistoSonics Inc., a medical device company whose backers include Johnson & Johnson’s venture capital arm, is weighing a US ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

One such company is Intuitive Surgical ( ISRG 0.11%). The medical device specialist's market cap currently tops $215 billion, ...

The company reported revenue of $22.5 billion and adjusted earnings of $2.04 per share, compared to the consensus estimates ...

Promising a “fight” to protect all Chicagoans, Mayor Brandon Johnson said yesterday he has not reached out to the White House in the face of Republican President Donald Trump’s ongoing threats against ...